Elevance Health Inc(ELV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 17.64 | EPS (ttm) | 22.5 | Insider Own | - | Shs Outstand | 216.8M | Perf Week | -1.52% |
| Market Cap | 86.08B | Forward P/E | 13.39 | EPS next Y | 9.16% | Insider Trans | - | Shs Float | 216.4M | Perf Month | -0.2% |
| Enterprise Value | - | PEG | 3.42 | EPS next Q | 4.66 | Inst Own | 94.75% | Short Float | 2.5% | Perf Quarter | -6.49% |
| Income | 4.96B | P/S | 0.43 | EPS this Y | -10.37% | Inst Trans | 0.58% | Short Ratio | 3.97 | Perf Half Y | 40.41% |
| Sales | 201.11B | P/B | 1.92 | EPS next 5Y | 3.92% | ROA | 4% | Short Interest | 5.41M | Perf YTD | 13.22% |
| Book/sh | 206.99 | P/C | - | EPS past 3/5Y | 1.27% 6.99% | ROE | 11.2% | 52W High | -9.02% ($436.24) | Perf Year | 25.96% |
| Cash/sh | - | P/FCF | 13.69 | Sales past 3/5Y | 8.34% 10.32% | ROIC | 6.57% | 52W Low | 44.41% ($274.84) | Perf 3Y | -11.55% |
| Dividend Est. | $6.9 (1.74%) | EV/EBITDA | - | EPS Y/Y TTM | -4.37% | Gross Margin | - | Volatility(W/M) | 2.22% 2.19% | Perf 5Y | 6.86% |
| Dividend TTM | 6.86 | EV/Sales | - | Sales Y/Y TTM | 6.27% | Oper. Margin | 3.63% | ATR (14) | 10.21 | Perf 10Y | 212.79% |
| Dividend Ex-Date | 2026/9/10 | Quick Ratio | - | EPS Q/Q | -13.02% | Profit Margin | 2.47% | RSI (14) | 48.87 | Recom | 1.88 |
| Dividend Gr. 3/5Y | 10.14% 12.47% | Current Ratio | 1.52 | Sales Q/Q | 1.4% | SMA20 | -0.79% ($400.06) | Beta | 0.71 | Target Price | $445.57 |
| Payout | 27.13% | Debt/Eq | 0.69 | Earnings | 2026/7/15 | SMA50 | 0.08% ($396.58) | Rel Volume | 0.89 | Prev Close | $401.94 |
| Employees | 97100 | LT Debt/Eq | 0.68 | EPS/Sales Surpr. | 19.94% 1.94% | SMA200 | 10.23% ($360.07) | Avg Volume(3M) | 1.36M | Price | $396.9 |
| IPO | 2001/10/30 | Option/Short | Yes/Yes | Trades | 18531 | Volume | 1,206,095 | Change | -1.25% |
Company
ELV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A leading company in the U.S. health insurance and medical services industry. Headquartered in Indianapolis, Indiana, it is a comprehensive health insurance group that holds numerous Blue Cross·Blue Shield licenses and has operated an extensive member base alongside integrated medical services.
Over the past 1 year, on the higher side
9% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend September 10
ELV has weak earning power
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -10.4% this year.
Tap to view numbers
The stock looks undervalued
Trading at 17.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by -11.6% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.74% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 94.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHF 0.07%
CAMX 0.06%
DIVE 0.04%
GFGF 0.04%
BEEX 0.04%It ranks #3 in the industry
Based on market cap of $86B.
ELV $86B PER 17.6
UNH $353B PER 25.3
CVS $122B PER 25.2
CI $74B PER 11.5
FAQ
What kind of company is ELV?
ELV belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of ELV?
The market cap of ELV is approximately $86.1B, ranking 193 within its sector.
Does ELV pay dividends?
ELV has a dividend yield of approximately 1.74%, with an annual dividend of $6.90.
What is the P/E ratio of ELV?
ELV has a P/E ratio of approximately 17.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ELV?
ELV has recorded a 52-week high of $436.24 and a low of $274.84.
